"Classical chemotherapy will lose ground in the next 10-20 years." Oncologist

The Nobel Committee announced the winners of the award in the field of medicine and physiology. They were James Ellison and Tasuku Hondzo, who opened the method of treating cancer by suppressing the negative work of the immune system. About how this study will change the situation in the fight against cancer, The Insider was told by the director of the Cancer Prevention Fund, oncologist Ilya Fomintsev .

I am personally deeply sure that if you give the Nobel Prize, then it is for this. I think this principle of therapy will radically change the approaches to the treatment of cancer in the next 10-20 years. My forecast - classical chemotherapy will lose ground and will practically become out of use in the coming decades, it will be replaced by targeted and immunotherapy. And about anthracyclines and dachshunds, then children in universities will tell children in the history of medicine, and they will scratch the backs and say: “Well, what kind of wildness, what a blessing that we live in the wrong time.”

This, of course, is just a wonderful thing. It actually changes the properties of cancer, its biology. When applying it, he loses a number of his abilities, which, in fact, allows people with fatal tumors to survive for so long when using it. A miracle, and nothing more. A cool thing, we are waiting for its distribution to all the localization of cancer.

Melanoma was an obvious goal. And here is the forecast (do not ask why I think so): the next in line will be the bladder cancer and colorectal cancer. I am directly sure that effective immunotherapeutic drugs will appear against them soon. But it is important to distinguish real immunotherapy from fakes and quackery. This is now in bulk.